CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- 8-K Event Results of operations
- POSASR Other POSASR
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President and CEO acquired 300,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 120,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 120,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 105,000 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 8-K Event Acquisition or sale completed
- 8-K Event Other events
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 8-K Event Executive or director change
- CT ORDER Other Confidential Order
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 20,000 shares at $3.62 ($72,402)
- 10-Q Report Quarterly Report
Page 14 of 32 · 633 filings